CSIMarket
 
Mylan N v   (MYL)
Other Ticker:  
 
 

Mylan N V Growth Comparisons

Select each growth Category to receive further Information



MYL Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 0.35% 9.79% 8.78% -2.04%
Q / Q Revenue Growth (Q3 MRQ) 8.82% 12.05% 14.32% 13.28%
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 179.14% 6.74% 4.3% -3.21%
Seq. Revenue Growth (for 12 months ending Q3 TTM) 0.06% 2.54% 2.18% -0.51%
Revenue 5 Year Average Growth 8.3% 12.04% 12.32% 10.69%
Expected Revenue Growth (Y/Y) -14.35% 2.5% 1.89% 0.98%


MYL's Growth Comparisons in III. Quarter 2020




Mylan N V 's Revenue slowed to the 0.35% year on year, improvement in the third quarter 2020 to 2.97 billions, underperforming the 9.79% growth in Major Pharmaceutical Preparations industry and 8.78% Revenue growth in the Healthcare sector. Above average sales gains in Healthcare and Major Pharmaceutical Preparations industry, helped to elevate overall market growth to -2.04%.

Comparing company's Revenue to the second quarter results, sales were higher by 8.82% . On the yearly basis, average annual sales growth for Mylan N V is 8.3%, while S & P 500's including only Businesses with the third quarter 2020 earnings, average annual sales growth is 10.69% over the past five years.


Growth Rates of MYL's Income in the third quarter 2020


MYL Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 8.56% -41.24% -4.04% -6.96%
Seq. Operating Income Change (Q3 MRQ) 161.85% 31.83% 102.58% 61.85%
Y / Y Operating Income Growth (Q3 TTM) 90.85% -13.81% 51.5% -9.43%
Seq. Operating Income Growth (Q3 TTM) 2.68% -15.18% -1.03% -3.12%
Operating Income 5 Year Avg. Change -11.96% 7.75% -0.83% 6.99%


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) -2.16% -22.55% 17.04% -12.87%
Seq. Income from Cont. Ops. Change (Q3 MRQ) 371.32% 15.59% 205.56% 108.35%
Y / Y Income from Cont. Ops. Change (Q3 TTM) 460.84% -6.59% 0.33% -29.6%
Seq. Income from Cont. Ops. Change (Q3 TTM) -1.52% -5.79% 4.65% -3.77%
Income from Cont. Ops. 5 Year Avg. Change -55.19% 6.25% 4.37% 34.84%

MYL Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) -2.16% -22.43% 18.18% -10.33%
Q / Q Net Income Growth (Q3 MRQ) 371.32% 15.46% 243.19% 113.32%
Y / Y Net Income Change (Q3 TTM) 460.84% -14.4% -4.93% -30.19%
Seq. Net Income Change (Q3 TTM) -1.52% -5.71% 5.12% -2.99%
Net Income 5 Year Avg. Growth -55.19% 7.3% 5.01% 35.68%

MYL's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) -2.7% 165.68% 17.04% -12.87%
Seq. EPS from Cont. Ops. Change (Q3 MRQ) 350% 12.42% 205.56% 108.35%
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 5.06% - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) -1.99% - - 1.99%
EPS from Cont. Ops. 5 Year Avg. Growth -58.68% -1.72% 4.37% 34.84%



MYL EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) -2.7% 166.1% 18.18% -10.33%
Q / Q EPS Net Growth (Q3 MRQ) 350% 12.29% 243.19% 113.32%
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - -43.85%
Seq. EPS Net Change (for 12 months ending Q3 TTM) -1.99% - - 1.2%
EPS Net 5 Year Avg. Change -58.16% 7.3% 5.01% 35.68%
Expected EPS Growth (Y/Y) 14066.67% - 123.59% 14.14%



Although the Major Pharmaceutical Preparations industry saw advancing EPS by 166.1%, Mylan N V announced -2.7% year on year income per share decline in the third quarter, to $ 0.36, and underperformed the 18.18% EPS improvement in the Healthcare sector. Above average income per share gains in Healthcare and Major Pharmaceutical Preparations industry, helped to elevate overall market growth to -10.33%.

Company's sequential EPS growth rate was impressive 350% from the second quarter. Average yearly income per share growth for Mylan N V is -58.16%, while S & P 500's average annual income per share growth is 35.68% over the five years, including only Businesses with the third quarter 2020 earnings results.

MYL Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) 7.63% -9.85% 2.64% -36.83%
Seq. Free Cash Flow Change (Q3 MRQ) 38.34% -6.95% -6.19% -38.06%
Y / Y Free Cash Flow Change (Q3 TTM) 7.37% 10.03% 12.27% -6.9%
Seq. Free Cash Flow Change (Q3 TTM) 2.02% -1.07% 1.39% -7.63%
Free Cash Flow 5 Year Avg. Change 18.2% 5.66% 6.74% 14.72%

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - 17.63% -25.04% -
Seq. Net Cash Flow Change (Q3 MRQ) - -54.31% 678.57% -
Y / Y Net Cash Flow Change (Q3 TTM) - -52% 59.88% -
Seq. Net Cash Flow Change (Q3 TTM) - 2.24% -8.34% -7.63%
Net Cash Flow 5 Year Avg. Change - - 63.07% 352.23%

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -9.91% 14.99% 3.85% -16.89%
Seq. Capital Expenditures Change (Q3 MRQ) -14.16% 20.85% 25.1% 0.55%
Y / Y Capital Expenditures Change (Q3 TTM) -21.47% 6.08% -10.03% -15.38%
Seq. Capital Expenditures Change (Q3 TTM) -2.06% 4.12% 1.51% -4.53%
Capital Expenditures 5 Year Avg. Change -8.1% 13.57% 23.09% 13.79%

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 





Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CINR's Profile

Stock Price

CINR's Financials

Business Description

Fundamentals

Charts & Quotes

CINR's News

Suppliers

CINR's Competitors

Customers & Markets

Economic Indicators

CINR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071